Efficacy and Toxicity of [177Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data
Related Posts
Czernin J. JNM Editors' Choice Awards for 2024. J Nucl Med. 2025 Jun 12:jnumed.125.270522. doi: 10.2967/jnumed.125.270522. Epub ahead of print. PMID: 40506241.
Palomurto S, Virtanen KA, Kärjä V, Schwab U, Kaminska D, Käkelä P, Pihlajamäki J, Männistö V. Metabolic dysfunction-associated steatotic liver disease alters fatty acid profiles[...]
Jeong SY, Gupta N, Qu Z, Ji S. Quantitative analyses of the distal bipolar electrogram for focal premature ventricular contraction ablation. J Arrhythm. 2025 Jun[...]